logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9132219 B1

PDFFull Text
Date of Patent:
Sep. 15, 2015

Filed:

Aug. 16, 2013

Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis

Applicants:

Baxter International Inc., Deerfield, IL (US);

Baxter Healthcare S.a., Glattpark (Opfikon), CH;

Inventors:

Alp Akonur, Evanston, IL (US);

John Kenneth Leypoldt, Libertyville, IL (US);

Yin-Cheng Lo, Green Oaks, IL (US);

Baris Ugar Agar, Chicago, IL (US);

Assignees:

Baxter International Inc., Deerfield, IL (US);

Baxter Healthcare SA, Glattpark (Opfikon), CH;

Attorney:

K&L Gates LLP

Primary Examiner:

Janet Suglo

Assistant Examiner:

Stephanie Bloss

Int. Cl.
CPC ...
G01N 33/48 (2006.01); A61M 1/16 (2006.01); A61M 1/36 (2006.01); G06F 19/00 (2011.01);
U.S. Cl.
CPC ...
A61M 1/16 (2013.01); A61M 1/1603 (2014.02); A61M 1/1611 (2014.02); A61M 1/1613 (2014.02); A61M 1/3609 (2014.02); G06F 19/3481 (2013.01);
Abstract

A method of predicting serum potassium concentrations in a patient during hemodialysis includes measuring serum potassium concentrations of the patient over a hemodialysis treatment session time and an ultrafiltration rate calculated by a difference between pre- and post-dialytic body weight of the patient during an initial hemodialysis treatment session divided by a total treatment time of the treatment session and estimating a potassium mobilization clearance and a pre-dialysis distribution volume of potassium for the patient. Serum potassium concentrations of the patient can then be predicted at any time during any hemodialysis treatment session with the estimated potassium mobilization clearance and pre-dialysis distribution volume of potassium of the patient.

Find Patent Forward Citations

Quick Actions:

Akonur, Alp. (2015). Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis (U.S. Patent No. 9132219). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9132219

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…